TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple ...
NEW YORK, Feb. 20, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of data presentations highlighting data from the ULTIMATE I & II Phase 3